Description
Gannet BioChem is a speciality CDMO based in Huntsville, Alabama, focused on polyethylene glycol (PEG) reagents for biopharmaceutical applications.
With over 30 years of expertise, Gannet BioChem has played a pivotal role in advancing PEGylation technology. Its FDA-inspected facility provides flexible manufacturing capabilities, supporting products from research stages to commercial-scale production. Originally operating as Shearwater Polymers and later a subsidiary of Nektar Therapeutics, the company now operates independently under Ampersand Capital Partners. Situated near one of the USA's leading life sciences hubs, Gannet BioChem supports several FDA-approved therapeutics and commercialised drugs.
Key Products and Services:
- End-to-end GMP manufacturing of PEG reagents.
- Development and scale-up for commercial manufacturing.
- Supply chain support for nine FDA-approved drugs.
- Custom PEG solutions for peptides, proteins, and antibody fragments.
- Flexible small-scale to large-scale production capacity.
Gannet BioChem combines decades of experience with state-of-the-art facilities, ensuring quality, innovation, and scalability for its partners in the biopharmaceutical industry. Positioned strategically in Alabama, the company is a trusted name in PEGylation technology